IFF Stock Quote
| Symbol: | IFF |
|---|---|
| Quote: | 79.20 |
| Change: | +0.05 |
| Change %: | +0.06% |
| High: | 79.35 |
| Low: | 78.23 |
| Open: | 79.04 |
|---|---|
| Volume: | 1,069,574 |
| 52 Week: | 65.85-106.77 |
| P/E Ratio: | 83.37 |
| EPS: | 0.95 |
| Market Cap: | 20.25 B |
Company Report
International Flavors & Fragrances Inc., along with its subsidiaries, is a leading manufacturer and supplier of cosmetic active ingredients and natural health ingredients used across a wide range of consumer products globally. Operating through four key segments Nourish, Scent, Health & Biosciences, and Pharma Solutions the company serves diverse markets spanning Europe, Africa, the Middle East, Greater Asia, North America, and Latin America. The Nourish segment specializes in natural and plant-based specialty food ingredients, flavor compounds, and savory solutions, catering to the food and beverage industry with natural antioxidants and antimicrobials that enhance product stability and shelf life.
The Scent segment focuses on fragrance compounds, including fine fragrances and consumer fragrances, as well as cosmetic active ingredients essential for personal care and cosmetic products. This segment offers a comprehensive portfolio of synthetic and natural fragrance ingredients that are blended to create unique scents and consumer compounds. Additionally, it develops active and functional ingredients and delivery systems to support the formulation needs of its customers in the cosmetics and personal care industries.
The Health & Biosciences segment is dedicated to producing enzymes, food cultures, probiotics, and specialty ingredients that enhance food texture, flavor, and nutritional value. Meanwhile, the Pharma Solutions segment manufactures and markets pharmaceutical excipients derived from cellulosics and seaweed, meeting the stringent requirements of the pharmaceutical industry. Founded in 1833 and headquartered in New York, New York, International Flavors & Fragrances Inc. continues to innovate and provide essential ingredients that shape the sensory experiences of consumers worldwide.
IFF EPS Chart
IFF Revenue Chart
IFF Profile
IFF News
NEW YORK--(BUSINESS WIRE)---- $IFF--IFF (NYSE: IFF) reported financial results for the first quarter ended March 31, 2025. First Quarter 2025 Consolidated Summary: Reported (GAAP) Adjusted (Non-GAAP)1 Sales Loss Before Taxes* EPS Operating EBITDA Operating EBITDA Margin EPS ex Amortization $2.8 B $(994) M $(3.98) $578 M 20.3% ... 5 hours ago |
Roquette Announces a New Organization following the Acquisition of IFF Pharma Solutions The company launches two renewed and strengthened Business Groups, and appoints their new leaders Lille, May 5, 2025 – Roquette, a global leader in plant-based ingredients and pharmaceutical excipients for the health and nutrition sectors, announces today a new ... 1 days ago |
NEW YORK--(BUSINESS WIRE)--IFF (NYSE: IFF) announced today the commencement of tender offers to purchase for cash certain of its outstanding series of notes listed in the tables below (collectively, the “Notes”) for an aggregate purchase price, excluding accrued and unpaid interest, of up to $1.8 billion. Pool 1 Tender Offers Pool 1 Maximum Amount:... 4 days ago |
NEW YORK--(BUSINESS WIRE)---- $IFF--IFF (NYSE: IFF) announced that its Board of Directors has declared a regular quarterly cash dividend of $0.40 per share of its common stock, payable on July 11, 2025 to shareholders of record as of June 20, 2025. Welcome to IFF At IFF (NYSE: IFF), we make joy through science, creativity and heart. As the global l... 5 days ago |
IFF's Q1 results are likely to reflect the impacts of improved volumes, offset by higher costs. 5 days ago |
Analyst Ratings